troxerutin은 임신 중 안전한가요?
Human epidemiological data (population case–control) linking oral hydroxyethylrutoside treatment during early pregnancy to increased risk of specific congenital abnormalities supports a 'suspected' reproductive hazard (see Pósfai et al. 2014). No harmonised CLP/SCCS/CIR reproductive classification for troxerutin was found. For topical cosmetic use dermal systemic exposure is expected to be negligible given troxerutin's high molecular weight and hydrophilicity, so exposure from cosmetics is rated negligible.
성분
troxerutin
중간 위험60
/100
0
임신 중 troxerutin 대체 안전 성분 | VeriMom
Related ingredients
Frequently asked questions
- troxerutin은 임신 중 안전한가요?
- Human epidemiological data (population case–control) linking oral hydroxyethylrutoside treatment during early pregnancy to increased risk of specific congenital abnormalities supports a 'suspected' reproductive hazard (see Pósfai et al. 2014). No harmonised CLP/SCCS/CIR reproductive classification for troxerutin was found. For topical cosmetic use dermal systemic exposure is expected to be negligible given troxerutin's high molecular weight and hydrophilicity, so exposure from cosmetics is rated negligible.
- troxerutin은 모유 수유 중 안전한가요?
- Animal reports indicate traces of hydroxyethylrutosides can be found in milk after systemic (oral) dosing; combined with the human epidemiology above this supports a suspected hazard for systemic use. For topical cosmetic use in the mother, systemic absorption is expected to be negligible and transfer via breast milk from topical use is considered negligible.
- troxerutin은 아기 피부에 안전한가요?
- Hazard is retained (suspected) because evidence exists for reproductive/ developmental effects with systemic exposures to hydroxyethylrutosides. Mechanistic reproductive toxicity data specific to troxerutin were not found. Dermal absorption from cosmetic use is expected to be very low in adults (e=0), but infant (0–3 yr) skin has increased permeability and higher surface-area-to-weight, so exposure is increased by +1 (e=1) compared with adults despite limited direct absorption data.
- VeriMom은 troxerutin을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 troxerutin을 60/100 (중간 위험)로 평가합니다.
- 임신 중 troxerutin 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.